CTRI/2021/12/038560尚未招募未知
Safety and efficacy of switching the antiplatelet regimen in patients from newer more potent P2Y2 inhibitors to clopidogrel at 1 month post PCI
N Mehta institute of cardiology and research center0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •ACS requiring early percutaneous
- •coronary intervention PCI within 72 h treatment with aspirin and a
- •newer P2Y12 blocker at discharge, no major adverse event one month
- •after the ACS and age greater than 18 years
排除标准
- •history of intracranial
- •bleeding, contraindication to use of aspirin, clopidogrel, prasugrel,
- •or ticagrelor; major adverse event
研究者
相似试验
已完成
4 期
The efficacy and safety of the antiplatelet therapy in acute non-cardiogenic ischemic stroke.on-cardiogenic ischemic stroke in acute phase.JPRN-UMIN000006931Department of Neurosurgery, Faculty of Medicine, University of Tsukuba130
终止
不适用
Comparison of the effect of an anti-platelet intervention with Ticagrelor versus placebo on participants with asymptomatic elevations in troponin TACTRN12614000189628Professor Derek Chew420
招募中
不适用
Safety and efficacy of 1-month dual antiplatelet therapy in high bleeding and ischemic risk elderly patients with coronary artery disease after implantation of zotarolimus-eluting coronary stent system (Resolute Onyx™ , Medtronic, Minneapolis, MN); A multicenter, prospective, observational studyFactors influencing health status and contact with health servicesKCT0008377Pusan National University Yangsan Hospital500
已完成
4 期
Efficacy and safety of change the antiplatelet agent in patients with chronic noncardioembolic ischemic stroke - multi-center prospective studynoncardioembolic ischemic strokeJPRN-UMIN000004611eurosurgery,Kawasaki Medical School120
已完成
不适用
Evaluation of the safety and efficacy of platelet rich plasma in treatment of patients with chronic telogen effluviumSkin and Connective Tissue DiseasesPACTR202006539654415Faculty of Medicine Sohag University30